Yüklüyor......
Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
BACKGROUND: Recently, we reported that the level of lathosterol, a cholesterol synthesis marker, was suppressed after 1 month of treatment with anagliptin, a dipeptidyl peptidase-4 inhibitor. In this study, we administered either anagliptin or miglitol, an alpha-glucosidase inhibitor, for 3 months i...
Kaydedildi:
| Yayımlandı: | J Clin Med Res |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elmer Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011936/ https://ncbi.nlm.nih.gov/pubmed/32095176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4084 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|